These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6152610)

  • 1. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Spence CD; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1984; 11(6):597-604. PubMed ID: 6152610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
    Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic response to ketanserin in rabbits with Page hypertension: comparison with prazosin.
    Wright CE; Angus JA
    J Hypertens; 1983 Aug; 1(2):183-90. PubMed ID: 6681038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin and alpha 1-adrenergic antagonism in humans.
    Zabludowski JR; Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S123-5. PubMed ID: 2412032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serotonin antagonists on blood pressure in mineralocorticoid hypertensive sheep.
    Mecca TE; Mitchell J; Bohr DF; Webb RC
    J Cardiovasc Pharmacol; 1985; 7(4):660-5. PubMed ID: 2410705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the hypotensive effect of ketanserin.
    Fozard JR
    J Cardiovasc Pharmacol; 1982; 4(5):829-38. PubMed ID: 6182416
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bucindolol has serotonin and alpha-adrenoceptor blocking properties.
    Marwood JF; Stokes GS
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S67-9. PubMed ID: 2412063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?
    Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S120-2. PubMed ID: 2412031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin does not prevent ACTH-induced hypertension in sheep.
    Nelson MA; Coghlan JP; Denton DA; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1985; 12(2):155-9. PubMed ID: 2988838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of the hypotensive effect of ketanserin.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketanserin on phenylephrine-dependent changes in splanchnic hemodynamics and systemic blood pressure in healthy subjects.
    Gasic S; Eichler HG; Korn A
    J Cardiovasc Pharmacol; 1985; 7(2):219-23. PubMed ID: 2581071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the serotonergic antagonist ketanserin.
    Stott DJ; Robertson JI; Ball SG
    J Hypertens Suppl; 1985 Dec; 3(3):S191-3. PubMed ID: 2856702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.
    Naslund TC; Merrell WJ; Nadeau JH; Wood AJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):699-703. PubMed ID: 2904312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.
    Smits J; van Dorsten F; Struyker Boudier H
    Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
    Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG
    Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.